![Patricia Pak Lee Chan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Patricia Pak Lee Chan
Fondateur chez Maverix Biomics, Inc.
Provenance du réseau au premier degré de Patricia Pak Lee Chan
Entité | Type d'entité | Industrie | |
---|---|---|---|
Maverix Biomics, Inc.
![]() Maverix Biomics, Inc. Miscellaneous Commercial ServicesCommercial Services Maverix Biomics, Inc. provides cloud-based platform to manage, analyze and visualize genomic data. It also builds communities of discovery and place its data in context with the latest public data from the full spectrum of life, including human, plant, animal or microbial organisms. The company was founded by David Mandelkern, Todd Michael Johnson Lowe and Patricia Pak Lee Chan in 2010 and is headquartered in San Mateo, CA.
7
| Holding Company | Miscellaneous Commercial Services | 7 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Patricia Pak Lee Chan via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Washington University in St. Louis | College/University | Corporate Officer/Principal Doctorate Degree | |
ANSYS, INC. | Packaged Software | Corporate Officer/Principal | |
Maxygen, Inc.
![]() Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Miscellaneous Commercial Services | Founder Director/Board Member | |
Apache Design Solutions, Inc.
![]() Apache Design Solutions, Inc. Packaged SoftwareTechnology Services Apache Design Solutions, Inc. provides power analysis and optimization software solutions. Its solutions include software tools and methodologies that enable design engineers to reduce power consumption, ensure delivery of power to ICs and electronic system components, and mitigate power-induced signal interference. The company was founded by Andrew T. Yang, Norman Chang and Shen Lin in January 2001 and it is headquartered in San Jose, CA. | Packaged Software | Founder | |
ALEXZA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Alavita Pharmaceuticals, Inc.
![]() Alavita Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alavita Pharmaceuticals, Inc. develops pharmaceutical therapeutic products. The company was founded on October 9, 2007 and is headquartered in Los Altos, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member | |
Access Health California
![]() Access Health California Medical/Nursing ServicesHealth Services Access Health (formerly QuickHealth Inc.) is a provider of primary care / immediate care medicine in a retail environment. The company provides expert medical care for minor injuries and illnesses, common chronic illnesses (like diabetes, high blood pressure, and asthma), physical exams, vaccinations, prescription refills, laboratory tests, and wellness exams. They offer primary and same day medical care in four locations around the Bay Area. Access Health was founded by David Mandelkern in 2004 and is headquartered in San Mateo, California. | Medical/Nursing Services | Chief Executive Officer | |
Protein Metrics, Inc.
![]() Protein Metrics, Inc. Information Technology ServicesTechnology Services Part of Insightful Science Holdings LLC, Protein Metrics, Inc. is a company that specializes in protein characterization. The company is based in Cupertino, CA at the crossroads of computing and biotechnology. The company's vendor-neutral software enables scientists to quickly identify and report protein sequences and variations from the expected form using data generated on analytical instruments like mass spectrometers. The company was founded by Yong Kil, Marshall Bern, Chris Becker, and Eric Carlson has been the CEO of the company since 2014. Protein Metrics was acquired by Insightful Science Holdings LLC on December 21, 2021. | Information Technology Services | Director/Board Member Director/Board Member | |
Cardiogen Sciences, Inc.
![]() Cardiogen Sciences, Inc. Pharmaceuticals: GenericHealth Technology Cardiogen Sciences, Inc. is a biotechnology company that develops and offers gene therapy solutions for orphan-inherited arrhythmogenic diseases. The company was founded by Louis G. Lange in 2014 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Generic | Founder | |
Stanford University | College/University | Graduate Degree | |
University of Washington
![]() University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Affymax Research Institute
![]() Affymax Research Institute Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, Affymax Research Institute is a company that researches and develops pharmaceutical products. The company is based in Palo Alto, CA. Affymax Research Institute was acquired by Affymax, Inc. from GSK Plc on July 30, 2001. | Miscellaneous Commercial Services | Chief Executive Officer | |
Ultima Interconnect Technology, Inc.
![]() Ultima Interconnect Technology, Inc. Information Technology ServicesTechnology Services Part of Cadence Design Systems, Inc., Ultima Interconnect Technology, Inc. is a company that provides IC interconnect analysis and synthesis tools. The company is based in Sunnyvale, CA. The company was founded by Wei-Ming Dai. | Information Technology Services | Director/Board Member | |
Oxonica Ltd.
![]() Oxonica Ltd. Miscellaneous Commercial ServicesCommercial Services Oxonica Ltd. is an advanced materials business, which engages in licensing of patents related to nanomaterials. The company was founded in 1999 and is headquartered in Birmingham, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Mojave, Inc.
![]() Mojave, Inc. SemiconductorsElectronic Technology Part of Synopsys, Inc., Mojave, Inc. develops integrated circuit manufacturability and verification technology. The company is based in Sunnyvale, CA. The company was founded in 2002 by Vivek Raghavan, Casey Jones, Murat Alaybeyi. Mojave was acquired by Magma Design Automation LLC on April 29, 2004 for $140 million. | Semiconductors | Director/Board Member | |
University of California, Berkeley | College/University | Undergraduate Degree | |
University of California, Santa Cruz | College/University | Undergraduate Degree Corporate Officer/Principal | |
University of Illinois | College/University | Doctorate Degree | |
SAGIMET BIOSCIENCES INC. | Pharmaceuticals: Major | Director/Board Member | |
ARDELYX, INC. | Pharmaceuticals: Major | Director/Board Member | |
Harvard Medical School | College/University | Doctorate Degree | |
InCarda Therapeutics, Inc.
![]() InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA. | Biotechnology | Director/Board Member | |
Apexigen America, Inc.
![]() Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA. | Pharmaceuticals: Major | Director/Board Member | |
Apache Design, Inc.
![]() Apache Design, Inc. Packaged SoftwareTechnology Services Part of ANSYS, Inc., Apache Design, Inc. manufactures and distributes power analysis and optimization software. The company is based in San Jose, CA. | Packaged Software | Chief Executive Officer | |
Technogen Associates LP | Corporate Officer/Principal | ||
AUDENTES THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Gladstone Foundation (CA) | Director/Board Member | ||
Amygdala Neurosciences, Inc.
![]() Amygdala Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Amygdala Neurosciences, Inc. is a biopharmaceutical company. The firm focuses on improving public health by developing and commercializing therapy to treat substance use disorders. Its development programs include treatment and prevention of opioid, nicotine, alcohol and cocaine use disorders. The company was founded by Lou Lange, Ivan Diamond, Peter Strumph, Brent Blackburn, and Adrienne MacMillan in 2015 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Founder | |
Quadriga BioSciences, Inc.
![]() Quadriga BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Quadriga BioSciences, Inc. is a privately held pharmaceutical company based in an undisclosed location. The American company is focused on developing proprietary targeted cancer therapies by exploiting the biology of aggressive forms of cancer cells that over-express certain unique amino acid transporters on their cell surfaces. The company's mission is to develop safer and more effective treatments for patients with cancer. The company was founded by Bernd Jandeleit, Kerry J. Koller, and Wolf-Nicolas Fischer. Gordon Ringold has been the CEO of the company since 2015. | Pharmaceuticals: Major | Chief Executive Officer | |
Revitope Oncology, Inc.
![]() Revitope Oncology, Inc. Hospital/Nursing ManagementHealth Services Revitope Oncology, Inc. develops a programmable antibody circuit pipeline in particular redirecting T cells to tumors. The company was founded by Andrew Allen and Mark Cobbold and is headquartered in Cambridge, MA. | Hospital/Nursing Management | Director/Board Member | |
STEALTH BIOTHERAPEUTICS CORP | Biotechnology | Director/Board Member | |
Teon Therapeutics, Inc.
![]() Teon Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Teon Therapeutics, Inc. operates as a pharmaceutical company. It focuses on cancer immunotherapy. The company was founded by Yao Lina, Fan Peidong, Elfaith Elzein, and Liiu Jiwen in March 2018 and is headquartered in Redwood City, CA. | Miscellaneous Commercial Services | Director/Board Member | |
DiNAQOR AG
![]() DiNAQOR AG BiotechnologyHealth Technology DiNAQOR AG is a Swiss genetic medicine platform company that focuses on developing innovative solutions for patients with severe, inherited forms of heart disease. The private company is based in Pfäffikon, Switzerland, and has additional presence in Massachusetts and other locations. The company's lead preclinical program, DINA-001, is aimed at treating mybpc3-linked cardiomyopathy. Founded in 2019, the CEO of DiNAQOR is Johannes Holzmeister. | Biotechnology | Director/Board Member | |
Okava Pharmaceuticals, Inc.
![]() Okava Pharmaceuticals, Inc. BiotechnologyHealth Technology Okava Pharmaceuticals, Inc. is an American clinical stage biotechnology company. | Biotechnology | Director/Board Member | |
EPIPHANY TECHNOLOGY ACQUISITION CORP. | Financial Conglomerates | Director/Board Member | |
NewAmsterdam Pharma Holding BV
![]() NewAmsterdam Pharma Holding BV BiotechnologyHealth Technology Part of NewAmsterdam Pharma Co. NV, NewAmsterdam Pharma Holding BV is a Dutch company that engages in research and development of transformative therapies for cardio metabolic diseases. The company is based in Naarden, the Netherlands. The company was founded in 2019 by John Jacob Pieter Kastelein. Michael H. Davidson has been the CEO of the company since 2020. NewAmsterdam Pharma Holding was acquired by Frazier Lifesciences Acquisition Corp. on November 22, 2022 for $468.74 million. | Biotechnology | Director/Board Member | |
BIOPLUS ACQUISITION CORP. | Financial Conglomerates | Director/Board Member | |
Recardia Therapeutics, Inc. | Director/Board Member | ||
ENTERPRISE 4.0 TECHNOLOGY ACQUISITION CORP. | Financial Conglomerates | Director/Board Member | |
APEXIGEN, INC. | Biotechnology | Director/Board Member | |
FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
Rapafusyn Pharmaceuticals
![]() Rapafusyn Pharmaceuticals Industrial SpecialtiesProcess Industries Rapafusyn Research & Development, Inc. develops non-degrading molecular glues. The company is based in Baltimore, MD. The CEO of the company is Sean X. Hu. | Industrial Specialties | Director/Board Member | |
NewAmsterdam Pharma BV
![]() NewAmsterdam Pharma BV Pharmaceuticals: MajorHealth Technology NewAmsterdam Pharma BV develops novel drugs to treat dyslipidemia. It operates as a biotechnology company and develops anti-dyslipidemic compounds in cardiovascular disease indications. The firm's product DEZ-001 develops a potent cholesteryl ester transfer protein inhibitor that has shown a decrease of low-density lipoprotein levels, and an increase of high-density lipoprotein levels. The company was founded by John J. P. Kastelein in 2012 and is headquartered in Naarden, the Netherlands. | Pharmaceuticals: Major | Director/Board Member |
Statistiques
Internationale
Etats-Unis | 46 |
Pays-Bas | 4 |
Royaume-Uni | 2 |
Suisse | 2 |
Sectorielle
Health Technology | 19 |
Technology Services | 11 |
Consumer Services | 8 |
Commercial Services | 6 |
Finance | 4 |
Opérationnelle
Director/Board Member | 43 |
Independent Dir/Board Member | 15 |
Corporate Officer/Principal | 15 |
Founder | 11 |
Chairman | 11 |
Relations les plus connectées
Insiders | |
---|---|
Louis Lange | 35 |
Gordon Ringold | 20 |
Andrew T. Yang | 13 |
David Mandelkern | 5 |
Todd Michael Johnson Lowe | 4 |
Thomas Kent | 1 |
Lior Pachter | 1 |
- Bourse
- Insiders
- Patricia Pak Lee Chan
- Connexions Sociétés